Santen Pharmaceutical to Leverage Medidata Edge CTMS to Drive Future Growth in Ophthalmic Clinical Development
Company adopts Edge CTMS in Japan as part of rapid global expansion February 20, 2018 08:30 AM Eastern Standard Time
NEW YORK – (BUSINESS WIRE) – Santen Pharmaceutical Co., Ltd, is expanding its use of the Medidata Clinical Cloud® with the adoption of Edge CTMS (Clinical Trial Management System) to support its clinical trial operations, in ophthalmology, across Japan, Asia, USA and the EU. Santen becomes the first sponsor to adopt Medidata Edge CTMS in the Japanese market.
Santen Pharmaceutical to leverage @Medidata Edge CTMS to drive future growth in ophthalmic clinical development
Medidata is the leading global provider of cloud-based technology and data analytics for clinical research. As Santen strives to globalize its research and development operations, the company will deploy Edge CTMS to streamline trial activities, increase productivity and improve efficiency of trial execution.
Edge CTMS provides real-time visibility into clinical trial milestones, allowing Santen to evaluate operational effectiveness and implement changes rapidly. It also seamlessly integrates with Rave EDC, the industry-leading EDC solution, enabling Santen to dramatically speed trial execution by managing both study and trial data on a single unified platform.
“There is a growing demand to simplify, improve efficiency and create transparency across clinical trials. The Medidata Edge CTMS solution makes it possible for life science companies to achieve all three on our unified platform,” said Glen de Vries, Medidata president and co-founder. “We look forward to strengthening our relationship with Santen, and helping to streamline workflows across their R&D, globally.”
As a specialized company dedicated to the ophthalmic field, Santen carries out research, development, marketing, and sales of pharmaceuticals. Santen is the market leader in Japan for prescription ophthalmic pharmaceuticals and sells products in approximately 60 countries. As a leading company in the field of ophthalmology, Santen aims to contribute to society by supplying valuable products and services to satisfy unmet medical needs. For more details, please see Santen’s website (www.santen.com).
Medidata’s unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech, medical device firms, academic medical centers and contract research organizations around the world. The Medidata Clinical Cloud® connects patients, physicians and life sciences professionals. Companies on the Medidata platform are individually and collaboratively reinventing the way research is done to create smarter, more precise treatments. For more information: www.mdsol.com